Viewing data from:

LARIN 24 FE

ANDA

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE | A202994 | NOVAST LABORATORIES LTD

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Larin 24 Fe (2023)

Total Spending

$68K

Total Claims

1,229

Beneficiaries

325

Avg Cost/Unit

$1.10

Spending Trend

$33K(2019)→$58K(2020)→$51K(2021)→$68K(2022)→$68K(2023)

YoY Change:-3.0%

5yr CAGR:-6.9%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.02MG;1MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Feb 18, 2015

No patent or exclusivity listings for this strength.